Please login to the form below

Not currently logged in
Email:
Password:

BMS appoints Murdo Gordon as chief commercial officer

He also becomes executive vice president

BMS Murdo GordonBristol-Myers Squibb has appointed Murdo Gordon to the newly-created position of executive vice president and chief commercial officer.

In this new role, Gordon will have responsibility for the New York-headquartered firm's global commercial strategy, as well as its new worldwide commercialisation team. He will report directly to BMS' chief executive Giovanni Caforio.

Gordon has nearly 30 years of industry experience with the biopharma company, having first joined its Canadian operations in 1989, where he held positions of increasing responsibility, including vice president of marketing, before moving to the US in 2003.

There he worked in a number of senior commercial leadership posts across the cardiovascular and neuroscience therapeutic areas, as well as in market access.

He was promoted to president of BMS' US operations in 2013, before taking on his most recent role as head of worldwide markets in January last year.

Gordon currently also serves a member of the board of directors for RWJBarnabas Health, a New Jersey-based comprehensive healthcare services provider.

22nd June 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics